Alexander Tenenbaum Selected Research

Heart Failure

1/2017	Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure.
9/2015	Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes.
11/2012	Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
1/2011	"The metabolic syndrome... is dead": these reports are an exaggeration.
7/2009	A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.
1/2008	Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
1/2008	Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
1/2007	Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency.
11/2006	Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality.
8/2006	Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Tenenbaum Research Topics

Disease

24	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2002
21	Type 2 Diabetes Mellitus (MODY) 11/2021 - 04/2002
16	Infarction (Infarctions) 10/2016 - 05/2002
15	Insulin Resistance 11/2021 - 12/2002
14	Dyslipidemias (Dyslipidemia) 11/2021 - 11/2004
14	Heart Failure 01/2017 - 09/2002
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 12/2002
14	Myocardial Infarction 01/2014 - 04/2002
13	Hypertension (High Blood Pressure) 01/2019 - 01/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2002
8	Atherosclerosis 01/2019 - 09/2003
8	Coronary Disease (Coronary Heart Disease) 03/2016 - 04/2004
6	Acute Coronary Syndrome 01/2020 - 12/2007
6	Diabetes Mellitus 10/2019 - 01/2004
6	Hypertriglyceridemia 03/2016 - 06/2005
5	Obesity 09/2015 - 12/2002
4	Thrombosis (Thrombus) 01/2014 - 01/2012
4	Heart Diseases (Heart Disease) 07/2009 - 05/2004
3	Unstable Angina 01/2022 - 07/2006
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2015 - 05/2004
3	Inflammation (Inflammations) 06/2014 - 10/2010
3	Ischemic Stroke 01/2014 - 07/2006
3	Edema (Dropsy) 11/2012 - 05/2004
3	Neoplasms (Cancer) 10/2010 - 04/2004
3	Lactic Acidosis 07/2009 - 05/2004
2	Hyperlipidemias (Hyperlipidemia) 09/2015 - 09/2006
2	Left Ventricular Dysfunction 09/2015 - 10/2010
2	Ischemia 01/2014 - 01/2012
2	Weight Gain 11/2012 - 07/2009
2	Overweight 11/2012 - 09/2005
2	Atherosclerotic Plaque (Atheroma) 11/2012 - 10/2010
2	Body Weight (Weight, Body) 07/2009 - 10/2005
2	Diarrhea 01/2008 - 05/2004
2	Vascular Diseases (Vascular Disease) 01/2008 - 05/2004
2	Stable Angina 04/2007 - 10/2003
2	Hyperinsulinism (Hyperinsulinemia) 01/2004 - 12/2002
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Magnesium Deficiency (Deficiency, Magnesium) 10/2019

Drug/Important Bio-Agent (IBA)

26	BezafibrateIBA 10/2016 - 05/2002
20	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 09/2002
14	Triglycerides (Triacylglycerol)IBA 01/2019 - 12/2004
12	LipidsIBA 11/2021 - 04/2002
11	HDL CholesterolIBA 01/2019 - 12/2004
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 12/2004
10	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2012 - 03/2003
8	Insulin (Novolin)FDA Link 01/2019 - 03/2003
8	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2004
8	Fibric Acids (Fibrates)IBA 11/2012 - 12/2004
7	Blood Glucose (Blood Sugar)IBA 01/2017 - 01/2004
7	LDL CholesterolIBA 09/2015 - 06/2005
7	CholesterolIBA 01/2012 - 05/2004
6	CytokinesIBA 12/2014 - 09/2003
6	CalciumIBA 01/2008 - 04/2002
5	oxidized low density lipoproteinIBA 12/2014 - 01/2008
5	LigandsIBA 01/2009 - 05/2004
4	BiguanidesIBA 09/2015 - 05/2004
4	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015 - 05/2004
4	LDL Lipoproteins (beta Lipoproteins)IBA 12/2014 - 09/2006
4	ThiazolidinedionesIBA 11/2012 - 05/2004
4	Nifedipine (Adalat)FDA LinkGeneric 06/2011 - 06/2002
3	InterleukinsIBA 01/2017 - 09/2003
3	AdiponectinIBA 09/2015 - 03/2007
3	Blood Coagulation Factors (Coagulation Factor)IBA 12/2014 - 05/2004
3	Fenofibrate (CiL)FDA LinkGeneric 10/2012 - 09/2006
3	Glyburide (Glibenclamide)FDA LinkGeneric 07/2009 - 05/2004
3	Adenosine Triphosphate (ATP)IBA 01/2008 - 03/2003
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2007 - 12/2002
3	fibric acidIBA 07/2006 - 05/2005
2	IncretinsIBA 11/2021 - 07/2009
2	PPAR alphaIBA 01/2019 - 03/2007
2	SodiumIBA 01/2019 - 12/2002
2	VildagliptinIBA 01/2017 - 06/2012
2	Nonesterified Fatty Acids (NEFA)IBA 12/2014 - 11/2012
2	Lipoproteins (Lipoprotein)IBA 12/2014 - 10/2012
2	HDL LipoproteinsIBA 12/2014 - 01/2008
2	PPAR gammaIBA 11/2012 - 09/2005
2	Therapeutic UsesIBA 10/2012 - 12/2004
2	Interleukin-6 (Interleukin 6)IBA 10/2010 - 07/2006
2	Simvastatin (Zocor)FDA LinkGeneric 06/2010 - 01/2008
2	LeptinIBA 07/2009 - 01/2004
2	Oxidoreductases (Dehydrogenase)IBA 01/2008 - 09/2006
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2008 - 05/2004
2	Potassium Channels (Potassium Channel)IBA 01/2008 - 05/2004
2	Ezetimibe (Zetia)FDA Link 01/2008 - 09/2006
2	Coenzyme A (CoA)IBA 01/2008 - 09/2006
2	HomocysteineIBA 01/2008 - 05/2004
2	Vitamin B Complex (B Vitamins)IBA 01/2008 - 05/2004
2	C-Reactive ProteinIBA 12/2007 - 07/2006
2	CreatinineIBA 03/2004 - 04/2002
2	Angiotensin Receptor AntagonistsIBA 01/2004 - 04/2002
2	Ramipril (Altace)FDA LinkGeneric 01/2004 - 12/2002
1	Calcineurin InhibitorsIBA 10/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019

Therapy/Procedure

20	Therapeutics 01/2019 - 03/2003
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2013
4	Secondary Prevention 07/2006 - 04/2004
3	Stents 01/2014 - 01/2012
2	Percutaneous Coronary Intervention 01/2022 - 01/2013
2	Heart Transplantation (Grafting, Heart) 10/2019 - 01/2019
2	Cardiac Rehabilitation 01/2017 - 01/2004